ATE173271T1 - Sterin epoxid verbindungen zur krebsbehandlung - Google Patents

Sterin epoxid verbindungen zur krebsbehandlung

Info

Publication number: ATE173271T1
Authority: AT; Austria
Prior art keywords: group; carbon atoms; hydroxyl group; sterol; cancer treatment
Prior art date: 1993-12-15

Application number

AT95902957T

Other languages

English (en)

Inventor

Chihiro Yokoo

Hisaya Wada

Hidemichi Mitome

Tatsuhiko Sano

Katsuo Hatayama

Yasuji Yamada

Original Assignee

Taisho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-15

Filing date

1994-12-14

Publication date

1998-11-15

1994-12-14 Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd

1998-11-15 Application granted granted Critical

1998-11-15 Publication of ATE173271T1 publication Critical patent/ATE173271T1/de

Links

239000004593 Epoxy Substances 0.000 title 1
206010028980 Neoplasm Diseases 0.000 title 1
229930182558 Sterol Natural products 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
150000003432 sterols Chemical class 0.000 title 1
235000003702 sterols Nutrition 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 6
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 4
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
150000003431 steroids Chemical class 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 1
125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
230000000259 anti-tumor effect Effects 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT95902957T 1993-12-15 1994-12-14 Sterin epoxid verbindungen zur krebsbehandlung ATE173271T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP31524693		1993-12-15

Publications (1)

Publication Number	Publication Date
ATE173271T1 true ATE173271T1 (de)	1998-11-15

Family

ID=18063133

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95902957T ATE173271T1 (de)	1993-12-15	1994-12-14	Sterin epoxid verbindungen zur krebsbehandlung

Country Status (9)

Country	Link
US (1)	US5712263A (de)
EP (1)	EP0735047B1 (de)
AT (1)	ATE173271T1 (de)
AU (1)	AU679302B2 (de)
CA (1)	CA2178900A1 (de)
DE (1)	DE69414602T2 (de)
DK (1)	DK0735047T3 (de)
ES (1)	ES2124995T3 (de)
WO (1)	WO1995016699A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999061055A1 (en)	1998-05-22	1999-12-02	The Board Of Trustees Of The Leland Stanford Junior University	Bifunctional molecules and therapies based thereon
JP4202250B2 (ja)	2001-07-25	2008-12-24	バイオマリンファーマシューティカルインコーポレイテッド	血液脳関門輸送を調節するための組成物および方法
DK1889198T3 (da)	2005-04-28	2015-02-09	Proteus Digital Health Inc	Farma-informatiksystem
JP2009508494A (ja)	2005-09-16	2009-03-05	ラプトールファーマシューティカルインコーポレイテッド	Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
CA2969926C (en)	2009-02-20	2018-05-15	2-Bbb Medicines B.V.	Glutathione-based drug delivery system
IL295075A (en)	2009-05-06	2022-09-01	Laboratory Skin Care Inc	Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5122521A (en) *	1990-07-17	1992-06-16	Taisho Pharmaceutical Co., Ltd.	Sterol compound

1994
- 1994-12-14 ES ES95902957T patent/ES2124995T3/es not_active Expired - Lifetime
- 1994-12-14 AT AT95902957T patent/ATE173271T1/de not_active IP Right Cessation
- 1994-12-14 AU AU12003/95A patent/AU679302B2/en not_active Ceased
- 1994-12-14 CA CA002178900A patent/CA2178900A1/en not_active Abandoned
- 1994-12-14 DK DK95902957T patent/DK0735047T3/da active
- 1994-12-14 DE DE69414602T patent/DE69414602T2/de not_active Expired - Fee Related
- 1994-12-14 EP EP95902957A patent/EP0735047B1/de not_active Expired - Lifetime
- 1994-12-14 WO PCT/JP1994/002102 patent/WO1995016699A1/ja active IP Right Grant
1996
- 1996-06-14 US US08/663,929 patent/US5712263A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2178900A1 (en)	1995-06-22
EP0735047A1 (de)	1996-10-02
DE69414602T2 (de)	1999-04-08
DE69414602D1 (de)	1998-12-17
DK0735047T3 (da)	1999-07-26
EP0735047A4 (de)	1996-11-27
AU679302B2 (en)	1997-06-26
ES2124995T3 (es)	1999-02-16
EP0735047B1 (de)	1998-11-11
US5712263A (en)	1998-01-27
WO1995016699A1 (fr)	1995-06-22
AU1200395A (en)	1995-07-03

Legal Events

Date	Code	Title	Description
1999-05-15	UEP	Publication of translation of european patent specification
2000-09-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
EP0611756A3 (de)	1994-11-30	Alkohol und Aldehyde Derivate als Cathepsin L Inhibitore und als Inhibitore der Knochenresorption.
ATE173271T1 (de)	1998-11-15	Sterin epoxid verbindungen zur krebsbehandlung
IL91382A0 (en)	1990-04-29	Substituted beta-diketones
EP0385446A3 (de)	1991-10-30	Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten
DE69800922D1 (de)	2001-07-19	Verfahren zur Herstellung von 2-Cyanobiphenyl Verbindungen
ATE265854T1 (de)	2004-05-15	Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
AU549554B2 (en)	1986-01-30	2,3-trimethylene-, tetramethylene- and pentamethylene- morpholines
GB8624686D0 (en)	1986-11-19	Preparing penems